ESR1 and breast carcinoma: Specifically, TRIM24 promotes p53 ubiquitination and proteasome-dependent degradation [47], and also interacts with chromatin and estrogen receptor to induce target genes controlling cell division and carcinogenesis in breast cancer [41].